Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Treasury Shares: 2018-2024

  • Arcturus Therapeutics Holdings' Treasury Shares changed negligibly% to $18,786 in Q4 2024 from the same period last year, while for Dec 2024 it was $18,786, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $18,786 for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q4 2024, Arcturus Therapeutics Holdings' Treasury Shares stood at $18,786, which was down 0.00% from $18,786 recorded in Q4 2023.
  • Arcturus Therapeutics Holdings' Treasury Shares' 5-year high stood at $18,786 during Q4 2023, with a 5-year trough of $18,786 in Q4 2023.
  • In the last 2 years, Arcturus Therapeutics Holdings' Treasury Shares had a median value of $18,786 in 2024 and averaged $18,786.